|
FR2640638B1
(fr)
|
1988-12-20 |
1991-02-15 |
Commissariat Energie Atomique |
Bioreacteur et dispositif pour la culture de cellules animales
|
|
AU7906691A
(en)
|
1990-05-23 |
1991-12-10 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
Adeno-associated virus (aav)-based eucaryotic vectors
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
|
US5587308A
(en)
|
1992-06-02 |
1996-12-24 |
The United States Of America As Represented By The Department Of Health & Human Services |
Modified adeno-associated virus vector capable of expression from a novel promoter
|
|
US6268213B1
(en)
|
1992-06-03 |
2001-07-31 |
Richard Jude Samulski |
Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy
|
|
US5387484A
(en)
|
1992-07-07 |
1995-02-07 |
International Business Machines Corporation |
Two-sided mask for patterning of materials with electromagnetic radiation
|
|
US5693531A
(en)
|
1993-11-24 |
1997-12-02 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vector systems for the generation of adeno-associated virus particles
|
|
EP0755454B1
(en)
|
1994-04-13 |
2008-02-13 |
The Rockefeller University |
Aav-mediated delivery of dna to cells of the nervous system
|
|
US20020159979A1
(en)
|
1994-06-06 |
2002-10-31 |
Children's Hospital, Inc. |
Adeno-associated virus materials and methods
|
|
US5658785A
(en)
|
1994-06-06 |
1997-08-19 |
Children's Hospital, Inc. |
Adeno-associated virus materials and methods
|
|
US6204059B1
(en)
|
1994-06-30 |
2001-03-20 |
University Of Pittsburgh |
AAV capsid vehicles for molecular transfer
|
|
US5856152A
(en)
|
1994-10-28 |
1999-01-05 |
The Trustees Of The University Of Pennsylvania |
Hybrid adenovirus-AAV vector and methods of use therefor
|
|
US5625048A
(en)
|
1994-11-10 |
1997-04-29 |
The Regents Of The University Of California |
Modified green fluorescent proteins
|
|
EP0796339A1
(en)
|
1994-12-06 |
1997-09-24 |
Targeted Genetics Corporation |
Packaging cell lines for generation of high titers of recombinant aav vectors
|
|
US5652224A
(en)
|
1995-02-24 |
1997-07-29 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism
|
|
US5741657A
(en)
|
1995-03-20 |
1998-04-21 |
The Regents Of The University Of California |
Fluorogenic substrates for β-lactamase and methods of use
|
|
US6281010B1
(en)
|
1995-06-05 |
2001-08-28 |
The Trustees Of The University Of Pennsylvania |
Adenovirus gene therapy vehicle and cell line
|
|
US5756283A
(en)
|
1995-06-05 |
1998-05-26 |
The Trustees Of The University Of Pennsylvania |
Method for improved production of recombinant adeno-associated viruses for gene therapy
|
|
US5688676A
(en)
|
1995-06-07 |
1997-11-18 |
Research Foundation Of State University Of New York |
In vitro packaging of adeno-associated virus DNA
|
|
US5741683A
(en)
|
1995-06-07 |
1998-04-21 |
The Research Foundation Of State University Of New York |
In vitro packaging of adeno-associated virus DNA
|
|
US6197293B1
(en)
|
1997-03-03 |
2001-03-06 |
Calydon, Inc. |
Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
|
|
US6676935B2
(en)
|
1995-06-27 |
2004-01-13 |
Cell Genesys, Inc. |
Tissue specific adenoviral vectors
|
|
WO1997008298A1
(en)
|
1995-08-30 |
1997-03-06 |
Genzyme Corporation |
Chromatographic purification of adenovirus and aav
|
|
US6265389B1
(en)
|
1995-08-31 |
2001-07-24 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of oligonucleotides
|
|
US5858351A
(en)
|
1996-01-18 |
1999-01-12 |
Avigen, Inc. |
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors
|
|
US5962313A
(en)
|
1996-01-18 |
1999-10-05 |
Avigen, Inc. |
Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme
|
|
US5846528A
(en)
|
1996-01-18 |
1998-12-08 |
Avigen, Inc. |
Treating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequence
|
|
US5952221A
(en)
|
1996-03-06 |
1999-09-14 |
Avigen, Inc. |
Adeno-associated virus vectors comprising a first and second nucleic acid sequence
|
|
US7026468B2
(en)
|
1996-07-19 |
2006-04-11 |
Valentis, Inc. |
Process and equipment for plasmid purification
|
|
WO1998010087A1
(en)
|
1996-09-06 |
1998-03-12 |
Trustees Of The University Of Pennsylvania |
Chimpanzee adenovirus vectors
|
|
CA2264499A1
(en)
|
1996-09-06 |
1998-03-12 |
The Trustees Of The University Of Pennsylvania |
Methods using cre-lox for production of recombinant adeno-associated viruses
|
|
US20020037867A1
(en)
|
1999-02-26 |
2002-03-28 |
James M. Wilson |
Method for recombinant adeno-associated virus-directed gene therapy
|
|
JP2001500015A
(ja)
|
1996-09-06 |
2001-01-09 |
トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
Ｔ７ポリメラーゼを利用する組換えアデノ随伴ウイルスの誘導可能な製造方法
|
|
WO1998009657A2
(en)
*
|
1996-09-06 |
1998-03-12 |
Trustees Of The University Of Pennsylvania |
Method for recombinant adeno-associated virus-directed gene therapy
|
|
US5866552A
(en)
|
1996-09-06 |
1999-02-02 |
The Trustees Of The University Of Pennsylvania |
Method for expressing a gene in the absence of an immune response
|
|
AU4645697A
(en)
|
1996-09-11 |
1998-04-02 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Aav4 vector and uses thereof
|
|
US7732129B1
(en)
|
1998-12-01 |
2010-06-08 |
Crucell Holland B.V. |
Method for the production and purification of adenoviral vectors
|
|
JP4492826B2
(ja)
|
1996-11-20 |
2010-06-30 |
イントロジェン セラピューティクス，インコーポレイテッド |
アデノウイルスベクターの産生および精製のための改良された方法
|
|
CA2270285A1
(en)
|
1996-12-18 |
1998-06-25 |
Targeted Genetics Corporation |
Aav split-packaging genes and cell lines comprising such genes for use in the production of recombinant aav vectors
|
|
NZ333334A
(en)
|
1997-04-17 |
2001-06-29 |
Frank L Sorgi |
Delivery system for gene therapy to the brain
|
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
US6710036B2
(en)
|
1997-07-25 |
2004-03-23 |
Avigen, Inc. |
Induction of immune response to antigens expressed by recombinant adeno-associated virus
|
|
US6251677B1
(en)
|
1997-08-25 |
2001-06-26 |
The Trustees Of The University Of Pennsylvania |
Hybrid adenovirus-AAV virus and methods of use thereof
|
|
US6995006B2
(en)
|
1997-09-05 |
2006-02-07 |
Targeted Genetics Corporation |
Methods for generating high titer helper-free preparations of released recombinant AAV vectors
|
|
US6566118B1
(en)
|
1997-09-05 |
2003-05-20 |
Targeted Genetics Corporation |
Methods for generating high titer helper-free preparations of released recombinant AAV vectors
|
|
CA2303768C
(en)
|
1997-09-19 |
2009-11-24 |
The Trustees Of The University Of Pennsylvania |
Methods and vector constructs useful for production of recombinant aav
|
|
EP1015619A1
(en)
|
1997-09-19 |
2000-07-05 |
The Trustees Of The University Of Pennsylvania |
Methods and cell line useful for production of recombinant adeno-associated viruses
|
|
AU9774998A
(en)
|
1997-09-19 |
1999-04-12 |
Trustees Of The University Of Pennsylvania, The |
Method for gene transfer using bcl2 and compositions useful therein
|
|
US6642051B1
(en)
|
1997-10-21 |
2003-11-04 |
Targeted Genetics Corporation |
Amplifiable adeno-associated virus(AAV) packaging cassettes for the production of recombinant AAV vectors
|
|
IT1297074B1
(it)
|
1997-11-21 |
1999-08-03 |
Angeletti P Ist Richerche Bio |
Forme ormone-dipendenti delle proteine rep del virus adeno-associato (aav-2), sequenze di dna codificanti per esse, vettori che le
|
|
NZ505325A
(en)
|
1997-12-23 |
2003-07-25 |
Crucell Holland B |
Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal dna of target cells
|
|
US6410300B1
(en)
|
1998-01-12 |
2002-06-25 |
The University Of North Carolina At Chapel Hill |
Methods and formulations for mediating adeno-associated virus (AAV) attachment and infection and methods for purifying AAV
|
|
AU2882899A
(en)
|
1998-02-26 |
1999-09-15 |
Trustees Of The University Of Pennsylvania, The |
Stable protection from dystrophic sarcolemmal degeneration and restoration of the sarcoglycan complex
|
|
US6953690B1
(en)
|
1998-03-20 |
2005-10-11 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
|
US6521426B1
(en)
|
1998-04-08 |
2003-02-18 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Preparation of recombinant adenovirus carrying a rep gene of adeno-associated virus
|
|
FR2778413B1
(fr)
|
1998-05-07 |
2000-08-04 |
Immunotech Sa |
Nouveaux reactifs et methode de lyse des erythrocytes
|
|
WO1999058700A1
(en)
|
1998-05-11 |
1999-11-18 |
Ariad Gene Therapeutics, Inc. |
Multiviral compositions and uses thereof
|
|
US6436392B1
(en)
|
1998-05-20 |
2002-08-20 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors
|
|
EP1849872A1
(en)
|
1998-05-20 |
2007-10-31 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors and uses thereof
|
|
EP1082445A2
(en)
|
1998-05-27 |
2001-03-14 |
Cell Genesys, Inc. |
Adeno-associated viral vector-mediated expression of factor viii activity
|
|
EP1080202B1
(en)
|
1998-05-27 |
2006-01-25 |
Avigen, Inc. |
Convection-enhanced delivery of aav vectors encoding aadc
|
|
WO1999061643A1
(en)
|
1998-05-27 |
1999-12-02 |
University Of Florida |
Method of preparing recombinant adeno-associated virus compositions by using an iodixananol gradient
|
|
WO1999061601A2
(en)
|
1998-05-28 |
1999-12-02 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Aav5 vector and uses thereof
|
|
US6984517B1
(en)
|
1998-05-28 |
2006-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
AAV5 vector and uses thereof
|
|
GB2338236B
(en)
|
1998-06-13 |
2003-04-09 |
Aea Technology Plc |
Microbiological cell processing
|
|
US6900049B2
(en)
|
1998-09-10 |
2005-05-31 |
Cell Genesys, Inc. |
Adenovirus vectors containing cell status-specific response elements and methods of use thereof
|
|
US6416992B1
(en)
|
1998-10-13 |
2002-07-09 |
Avigen, Inc. |
Compositions and methods for producing recombinant adeno-associated virus
|
|
US6200560B1
(en)
|
1998-10-20 |
2001-03-13 |
Avigen, Inc. |
Adeno-associated virus vectors for expression of factor VIII by target cells
|
|
EP1124976A1
(en)
|
1998-10-27 |
2001-08-22 |
Crucell Holland B.V. |
Improved aav vector production
|
|
US6759237B1
(en)
|
1998-11-05 |
2004-07-06 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
|
DE69941905D1
(de)
|
1998-11-10 |
2010-02-25 |
Univ North Carolina |
Virusvektoren und verfahren für ihre herstellung und verabreichung.
|
|
US6689600B1
(en)
|
1998-11-16 |
2004-02-10 |
Introgen Therapeutics, Inc. |
Formulation of adenovirus for gene therapy
|
|
US6759050B1
(en)
|
1998-12-03 |
2004-07-06 |
Avigen, Inc. |
Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
|
|
US6225113B1
(en)
|
1998-12-04 |
2001-05-01 |
Genvec, Inc. |
Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene in an at least E4-deficient adenovirus
|
|
US6387368B1
(en)
|
1999-02-08 |
2002-05-14 |
The Trustees Of The University Of Pennsylvania |
Hybrid adenovirus-AAV virus and methods of use thereof
|
|
DE19905501B4
(de)
|
1999-02-10 |
2005-05-19 |
MediGene AG, Gesellschaft für molekularbiologische Kardiologie und Onkologie |
Verfahren zur Herstellung eines rekombinanten Adeno-assoziierten Virus, geeignete Mittel hierzu sowie Verwendung zur Herstellung eines Arzneimittels
|
|
US6509150B1
(en)
|
1999-03-05 |
2003-01-21 |
Universite De Nantes |
Compositions and methods for recombinant Adeno-Associated Virus production
|
|
US6258595B1
(en)
|
1999-03-18 |
2001-07-10 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
|
JP4693244B2
(ja)
|
1999-03-18 |
2011-06-01 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
組換えアデノ随伴ウイルスのヘルパー無しの生産のための組成物および方法
|
|
JP2002542805A
(ja)
|
1999-04-30 |
2002-12-17 |
ユニバーシティ オブ フロリダ |
アデノ随伴ウイルス送達リボザイム組成物および使用方法
|
|
AU2409200A
(en)
|
1999-06-02 |
2000-12-28 |
Trustees Of The University Of Pennsylvania, The |
Compositions and methods useful for production of recombinant viruses which require helper viruses
|
|
JP4969002B2
(ja)
|
1999-06-08 |
2012-07-04 |
ユニバーシテイ・オブ・アイオワ・リサーチ・フアウンデーシヨン |
ｒＡＡＶ形質導入を増加するための化合物および方法
|
|
WO2001014539A2
(en)
|
1999-08-20 |
2001-03-01 |
Johns Hopkins University School Of Medicine |
Methods and compositions for the construction and use of fusion libraries
|
|
US6365394B1
(en)
|
1999-09-29 |
2002-04-02 |
The Trustees Of The University Of Pennsylvania |
Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus
|
|
EP1218035A2
(en)
|
1999-09-29 |
2002-07-03 |
The Trustees Of The University Of Pennsylvania |
Rapid peg-modification of viral vectors
|
|
US7241447B1
(en)
|
1999-10-07 |
2007-07-10 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors and uses thereof
|
|
WO2001025465A1
(en)
|
1999-10-07 |
2001-04-12 |
University Of Iowa Research Foundation |
Adeno-associated viruses and uses thereof
|
|
WO2001032711A2
(en)
|
1999-10-21 |
2001-05-10 |
Board Of Trustees Of The University Of Arkansas |
Adeno-associated virus aav rep78 major regulatory protein, mutants thereof and uses thereof
|
|
WO2001036623A2
(en)
|
1999-11-05 |
2001-05-25 |
Avigen, Inc. |
Ecdysone-inducible adeno-associated virus expression vectors
|
|
WO2001036603A2
(en)
|
1999-11-17 |
2001-05-25 |
Avigen, Inc. |
Recombinant adeno-associated virus virions for the treatment of lysosomal disorders
|
|
EP1240345A2
(en)
|
1999-12-10 |
2002-09-18 |
Ariad Gene Therapeutics, Inc. |
Methods for expression of genes in primates
|
|
US7638120B2
(en)
|
2000-03-14 |
2009-12-29 |
Thomas Jefferson University |
High transgene expression of a pseudotyped adeno-associated virus type
|
|
WO2001068888A2
(en)
|
2000-03-14 |
2001-09-20 |
Neurologix, Inc. |
Production of chimeric capsid vectors
|
|
US6468524B1
(en)
|
2000-03-22 |
2002-10-22 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
AAV4 vector and uses thereof
|
|
US6855314B1
(en)
|
2000-03-22 |
2005-02-15 |
The United States Of America As Represented By The Department Of Health And Human Services |
AAV5 vector for transducing brain cells and lung cells
|
|
US7048920B2
(en)
|
2000-03-24 |
2006-05-23 |
Cell Genesys, Inc. |
Recombinant oncolytic adenovirus for human melanoma
|
|
GB0009887D0
(en)
|
2000-04-20 |
2000-06-07 |
Btg Int Ltd |
Cytotoxic agents
|
|
WO2001083692A2
(en)
|
2000-04-28 |
2001-11-08 |
The Trustees Of The University Of Pennsylvania |
Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
|
|
US20030013189A1
(en)
|
2000-04-28 |
2003-01-16 |
Wilson James M. |
Compositions and methods useful for non-invasive delivery of therapeutic molecules to the bloodstream
|
|
US7125705B2
(en)
|
2000-04-28 |
2006-10-24 |
Genzyme Corporation |
Polynucleotides for use in recombinant adeno-associated virus virion production
|
|
CA2409674C
(en)
|
2000-05-23 |
2010-05-11 |
Neurologix, Inc. |
Glutamic acid decarboxylase (gad) based delivery systems
|
|
WO2001092551A2
(en)
|
2000-06-01 |
2001-12-06 |
University Of North Carolina At Chapel Hill |
Duplexed parvovirus vectors
|
|
US20020106381A1
(en)
|
2000-06-13 |
2002-08-08 |
High Katherine A. |
Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus
|
|
US7045299B2
(en)
|
2000-07-18 |
2006-05-16 |
Takeda Pharmaceutical Company Limited |
Physiologically active peptide and use thereof
|
|
US6593123B1
(en)
|
2000-08-07 |
2003-07-15 |
Avigen, Inc. |
Large-scale recombinant adeno-associated virus (rAAV) production and purification
|
|
US6329181B1
(en)
|
2000-08-07 |
2001-12-11 |
Neurologix, Inc. |
Helper functions for recombinant vector production
|
|
WO2002014487A2
(en)
|
2000-08-17 |
2002-02-21 |
Keiya Ozawa |
Adeno-associated virus-mediated delivery of angiogenic factors
|
|
DE10066104A1
(de)
|
2000-09-08 |
2003-01-09 |
Medigene Ag |
Wirtszellen zur Verpackung von rekombinantem Adeno-assoziiertem Virus (rAAV), Verfahren zu ihrer Herstellung und deren Verwendung
|
|
FR2813891B1
(fr)
|
2000-09-14 |
2005-01-14 |
Immunotech Sa |
Reactif multifonctionnel pour erythrocytes mettant en jeu des carbamates et applications
|
|
JP2002153278A
(ja)
|
2000-11-22 |
2002-05-28 |
Hisamitsu Pharmaceut Co Inc |
ウイルスベクターの製造に用いられる細胞、その製法およびその細胞を用いたウイルスベクターの製造方法
|
|
WO2002070719A2
(en)
|
2001-01-19 |
2002-09-12 |
Trustees Of The University Of Pennsylvania |
Regulatable gene expression system
|
|
CA2441454A1
(en)
|
2001-03-14 |
2002-09-19 |
Avigen, Inc. |
Recombinant adeno-associated virus-mediated gene transfer via retroductal infusion of virions
|
|
US7588757B2
(en)
|
2001-03-14 |
2009-09-15 |
Genzyme Corporation |
Methods of treating Parkinson's disease using recombinant adeno-associated virus virions
|
|
US20040136963A1
(en)
|
2001-06-22 |
2004-07-15 |
The Trustees Of The University Of Pennsylvania |
Simian adenovirus vectors and methods of use
|
|
JP4399255B2
(ja)
|
2001-06-22 |
2010-01-13 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
細菌の形質転換体を迅速に選別する方法および新規なサルアデノウイルス蛋白質
|
|
US8241622B2
(en)
|
2001-07-13 |
2012-08-14 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences
|
|
EP1279740A1
(en)
|
2001-07-26 |
2003-01-29 |
Vrije Universiteit Brussel |
Recombinant vector derived from adeno-associated virus for gene therapy
|
|
ES2564553T3
(es)
|
2001-08-08 |
2016-03-23 |
The Trustees Of The University Of Pennsylvania |
Procedimiento para purificar vectores víricos que tienen proteínas que se unen a ácido siálico
|
|
US20030092161A1
(en)
|
2001-09-19 |
2003-05-15 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for production of recombinant viruses, and uses therefor
|
|
EP1572893B1
(en)
|
2001-11-09 |
2009-01-07 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY of the DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Production of adeno-associated virus in insect cells
|
|
US6723551B2
(en)
|
2001-11-09 |
2004-04-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of adeno-associated virus in insect cells
|
|
SG168422A1
(en)
|
2001-11-13 |
2011-02-28 |
Univ Pennsylvania |
A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
|
|
HU230364B1
(hu)
|
2001-11-21 |
2016-03-29 |
The Trustees Of The University Of Pennsylvania |
Simian adenovírus nukleinsav és aminosav-szekvencia, azt tartalmazó vektorok, és eljárások annak alkalmazására
|
|
EP1944043A1
(en)
|
2001-11-21 |
2008-07-16 |
The Trustees of the University of Pennsylvania |
Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
|
|
JP4550421B2
(ja)
|
2001-12-12 |
2010-09-22 |
メイン・ファ−マ・インタ−ナショナル・プロプライエタリ−・リミテッド |
ウイルスの保存のための組成物
|
|
JP4810062B2
(ja)
|
2001-12-17 |
2011-11-09 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
アデノ随伴ウイルス（ａａｖ）血清型８の配列
|
|
ES2526341T3
(es)
|
2001-12-17 |
2015-01-09 |
The Trustees Of The University Of Pennsylvania |
Secuencias de serotipo 9 de virus adeno-asociado (AAV), vectores que las contienen, y usos de las mismas
|
|
AU2002359786A1
(en)
|
2001-12-19 |
2003-07-09 |
Hiroaki Mizukami |
Adeno-associated virus-mediated delivery of gdnf to skeletal muscles
|
|
AU2003202026A1
(en)
|
2002-01-16 |
2003-09-02 |
Dynal Biotech Asa |
Method for isolating nucleic acids and protein from a single sample
|
|
GB0208390D0
(en)
|
2002-04-11 |
2002-05-22 |
Univ London |
Adeno-associated virus producer system
|
|
US20030198620A1
(en)
|
2002-04-16 |
2003-10-23 |
Keiya Ozawa |
Method of treating amino acid metabolic disorders using recombinant adeno-associated virus virions
|
|
EP1359217B1
(en)
|
2002-04-29 |
2006-12-13 |
The Trustees of The University of Pennsylvania |
Method for direct rescue and amplification of integrated viruses from cellular DNA of tissues
|
|
NZ535944A
(en)
|
2002-04-30 |
2007-11-30 |
Oncolytics Biotech Inc |
Viral purification method comprising a simple extraction step in which a detergent is directly added to the cell culture, thereafter, cell debris is removed from the extraction mixture by filtration or centrifugation
|
|
AU2003295312B2
(en)
|
2002-05-01 |
2008-08-14 |
University Of Florida Research Foundation, Inc. |
Improved rAAV expression systems for genetic modification of specific capsid proteins
|
|
US7326555B2
(en)
|
2002-05-14 |
2008-02-05 |
Merck & Co., Inc. |
Methods of adenovirus purification
|
|
US7419817B2
(en)
|
2002-05-17 |
2008-09-02 |
The United States Of America As Represented By The Secretary Department Of Health And Human Services, Nih. |
Scalable purification of AAV2, AAV4 or AAV5 using ion-exchange chromatography
|
|
US20070015238A1
(en)
|
2002-06-05 |
2007-01-18 |
Snyder Richard O |
Production of pseudotyped recombinant AAV virions
|
|
JP2006515162A
(ja)
|
2002-08-29 |
2006-05-25 |
ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ |
環状核酸ベクター、ならびに同ベクターの作製法および使用法
|
|
US7169612B2
(en)
|
2002-11-11 |
2007-01-30 |
Sanofi-Aventis Deutschland Gmbh |
Use of EDG2 receptor in an animal model of heart failure
|
|
EP1418185A1
(en)
|
2002-11-11 |
2004-05-12 |
Aventis Pharma Deutschland GmbH |
Use of EDG2 receptor in an animal model of heart failure
|
|
US8946151B2
(en)
|
2003-02-24 |
2015-02-03 |
Northern Bristol N.H.S. Trust Frenchay Hospital |
Method of treating Parkinson's disease in humans by convection-enhanced infusion of glial cell-line derived neurotrophic factor to the putamen
|
|
WO2004075861A2
(en)
|
2003-02-26 |
2004-09-10 |
Children's Hospital, Inc. |
Recombinant adeno-associated virus production
|
|
US20070172460A1
(en)
|
2003-03-19 |
2007-07-26 |
Jurgen Kleinschmidt |
Random peptide library displayed on aav vectors
|
|
WO2004108922A2
(en)
|
2003-04-25 |
2004-12-16 |
The Trustees Of The University Of Pennsylvania |
Use of aav comprising a capsid protein from aav7 or aav8 for the delivery of genes encoding apoprotein a or e genes to the liver
|
|
US8927269B2
(en)
|
2003-05-19 |
2015-01-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Avian adenoassociated virus and uses thereof
|
|
JP4559429B2
(ja)
|
2003-05-21 |
2010-10-06 |
ジェンザイム・コーポレーション |
空キャプシドを実質的に含まない組換えａａｖビリオン調製物を生成するための方法
|
|
EP1486567A1
(en)
|
2003-06-11 |
2004-12-15 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Improved adeno-associated virus (AAV) vector for gene therapy
|
|
JP4888876B2
(ja)
|
2003-06-13 |
2012-02-29 |
田平 武 |
アルツハイマー病の治療のための組換えアデノ随伴ウィルスベクター
|
|
PL2357189T3
(pl)
|
2003-06-19 |
2017-08-31 |
Genzyme Corporation |
Wiriony AAV o zmniejszonej immunoreaktywności i ich zastosowanie
|
|
US7291498B2
(en)
|
2003-06-20 |
2007-11-06 |
The Trustees Of The University Of Pennsylvania |
Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
|
|
EP1636370B1
(en)
|
2003-06-20 |
2014-04-16 |
The Trustees of The University of Pennsylvania |
Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
|
|
US9441244B2
(en)
|
2003-06-30 |
2016-09-13 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
|
US9233131B2
(en)
|
2003-06-30 |
2016-01-12 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
|
WO2005012537A2
(en)
|
2003-07-25 |
2005-02-10 |
Genvec, Inc. |
Adenoviral vector-based vaccines
|
|
EP1648914A4
(en)
*
|
2003-07-31 |
2009-12-16 |
Regulus Therapeutics Inc |
OLIGOMERIC COMPOUNDS AND COMPOSITIONS USEFUL FOR MODULATING SMALL NON-CODING RNA
|
|
US20070073264A1
(en)
|
2003-09-26 |
2007-03-29 |
The Trustees Of The University Of Pennsylvania |
Methods, compositions and apparatus for delivering heterologous molecules to cells
|
|
EP3910063A1
(en)
|
2003-09-30 |
2021-11-17 |
The Trustees of The University of Pennsylvania |
Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
|
|
WO2005056807A2
(en)
|
2003-12-04 |
2005-06-23 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, National Institutes Of Health |
Bovine adeno-associated viral (baav) vector and uses thereof
|
|
US20060166363A1
(en)
|
2004-01-27 |
2006-07-27 |
Sergei Zolotukhin |
Modified baculovirus expression system for production of pseudotyped rAAV vector
|
|
ES2361000T3
(es)
|
2004-04-28 |
2011-06-13 |
The Trustees Of The University Of Pennsylvania |
Suministro secuencial de moléculas inmunogénicas mediante administraciones de un adenovirus y de un virus adeno-asociado.
|
|
HUE060433T2
(hu)
|
2004-06-01 |
2023-03-28 |
Genzyme Corp |
Készítmények és eljárások AAV vektor aggregációjának megelõzésére
|
|
US7427396B2
(en)
|
2004-06-03 |
2008-09-23 |
Genzyme Corporation |
AAV vectors for gene delivery to the lung
|
|
CA2581714C
(en)
|
2004-10-05 |
2017-09-12 |
Avigen, Inc. |
Stepped cannula
|
|
US7901921B2
(en)
|
2004-10-22 |
2011-03-08 |
Oncolytics Biotech Inc. |
Viral purification methods
|
|
CN1286981C
(zh)
|
2004-11-30 |
2006-11-29 |
华中科技大学同济医学院附属同济医院 |
表达人类cyp2j2反义基因的重组腺相关病毒及其制备方法
|
|
US8614101B2
(en)
|
2008-05-20 |
2013-12-24 |
Rapid Pathogen Screening, Inc. |
In situ lysis of cells in lateral flow immunoassays
|
|
AU2006222012B2
(en)
*
|
2005-03-08 |
2011-03-31 |
Basf Plant Science Gmbh |
Expression enhancing intron sequences
|
|
US7625570B1
(en)
|
2005-03-10 |
2009-12-01 |
The Regents Of The University Of California |
Methods for purifying adeno-associated virus
|
|
WO2006102072A2
(en)
|
2005-03-23 |
2006-09-28 |
The Trustees Of The University Of Pennsylvania |
Use of a pa131 polypeptide in treatment of atherosclerosis
|
|
EP3409296A1
(en)
|
2005-04-07 |
2018-12-05 |
The Trustees of the University of Pennsylvania |
Method of increasing the function of an aav vector
|
|
WO2006119432A2
(en)
|
2005-04-29 |
2006-11-09 |
The Government Of The U.S.A., As Rep. By The Sec., Dept. Of Health & Human Services |
Isolation, cloning and characterization of new adeno-associated virus (aav) serotypes
|
|
BRPI0611379A2
(pt)
|
2005-05-02 |
2010-08-31 |
Genzyme Corp |
terapia genética para distúrbios neurometabólicos
|
|
SI2002003T1
(sl)
|
2005-05-27 |
2016-05-31 |
Ospedale San Raffaele S.R.L. |
Genski vektor, ki vsebuje mi-RNA
|
|
ES2937245T3
(es)
|
2005-08-23 |
2023-03-27 |
Univ Pennsylvania |
ARN que contiene nucleósidos modificados y métodos de uso del mismo
|
|
US9089667B2
(en)
|
2005-08-23 |
2015-07-28 |
The Regents Of The University Of California |
Reflux resistant cannula and system for chronic delivery of therapeutic agents using convection-enhanced delivery
|
|
EP1857552A1
(en)
|
2006-05-20 |
2007-11-21 |
Cargill Incorporated |
Thermostable xylose isomerase enzyme
|
|
PL1945779T3
(pl)
|
2005-10-20 |
2013-08-30 |
Uniqure Ip Bv |
Ulepszone wektory AAV produkowane w komórkach owadzich
|
|
WO2008016391A2
(en)
|
2006-01-31 |
2008-02-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Self-complementary parvoviral vectors, and methods for making and using the same
|
|
EP2007795B1
(en)
|
2006-03-30 |
2016-11-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Aav capsid proteins
|
|
AU2007244826B2
(en)
|
2006-04-25 |
2013-04-11 |
The Regents Of The University Of California |
Administration of growth factors for the treatment of CNS disorders
|
|
ATE455558T1
(de)
|
2006-04-28 |
2010-02-15 |
Univ Pennsylvania |
Modifiziertes adenovirus-hexon-protein und anwendungen davon
|
|
CN101495624A
(zh)
|
2006-04-28 |
2009-07-29 |
宾夕法尼亚州立大学托管会 |
衣壳免疫原性降低的经修饰aav载体及其用途
|
|
JP5268890B2
(ja)
|
2006-04-28 |
2013-08-21 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
Ａａｖの規模適応性の製造方法
|
|
US8298818B2
(en)
|
2006-04-28 |
2012-10-30 |
University Of Florida Research Foundation, Inc. |
Self-complementary adeno-associated virus having a truncated CMV-chicken β-actin promoter
|
|
WO2007130519A2
(en)
|
2006-05-02 |
2007-11-15 |
Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services |
Viral nucleic acid microarray and method of use
|
|
DK2687223T4
(da)
|
2006-05-30 |
2025-02-17 |
Mayo Found Medical Education & Res |
Påvisning og behandling af demens
|
|
MX364444B
(es)
|
2006-06-07 |
2019-04-26 |
Genzyme Corp |
Terapia génica para esclerosis lateral amiotrófica y otros trastornos de la médula espinal.
|
|
EP2037892B1
(en)
|
2006-06-19 |
2015-03-18 |
Asklepios Biopharmaceutical, Inc. |
Modified factor viii and factor ix genes and vectors for gene therapy
|
|
CA2655957C
(en)
|
2006-06-21 |
2016-05-03 |
Amsterdam Molecular Therapeutics (Amt) B.V. |
Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav in insect cells
|
|
ES2428067T3
(es)
|
2006-07-21 |
2013-11-05 |
California Institute Of Technology |
Introducción selectiva de genes para la vacunación con células dendríticas
|
|
EP2061891B1
(en)
|
2006-08-24 |
2012-04-11 |
Virovek, Inc. |
Expression in insect cells of genes with overlapping open reading frames, methods and compositions therefor
|
|
CA2693178C
(en)
|
2006-11-29 |
2018-12-04 |
Nationwide Children's Hospital, Inc. |
Myostatin inhibition for enhancing muscle and/or improving muscle function
|
|
US20120322861A1
(en)
|
2007-02-23 |
2012-12-20 |
Barry John Byrne |
Compositions and Methods for Treating Diseases
|
|
US9725485B2
(en)
|
2012-05-15 |
2017-08-08 |
University Of Florida Research Foundation, Inc. |
AAV vectors with high transduction efficiency and uses thereof for gene therapy
|
|
EP3492596A1
(en)
|
2007-04-09 |
2019-06-05 |
University of Florida Research Foundation, Inc. |
Raav vector compositions having tyrosine-modified capsid proteins and methods for use
|
|
US9611302B2
(en)
|
2007-04-09 |
2017-04-04 |
University Of Florida Research Foundation, Inc. |
High-transduction-efficiency RAAV vectors, compositions, and methods of use
|
|
WO2008128251A1
(en)
|
2007-04-17 |
2008-10-23 |
The Children's Hospital Of Philadelphia |
Humanized viral vectors and methods of use thereof
|
|
ES2602610T3
(es)
|
2007-05-31 |
2017-02-21 |
Medigene Ag |
Proteína estructural mutada de un parvovirus
|
|
EP2012122A1
(en)
|
2007-07-06 |
2009-01-07 |
Medigene AG |
Mutated parvovirus structural proteins as vaccines
|
|
PT3252161T
(pt)
|
2007-06-06 |
2022-02-01 |
Genzyme Corp |
Terapia genética para doenças do armazenamento lisossomal
|
|
RU2491344C2
(ru)
|
2007-06-29 |
2013-08-27 |
Ф.Хоффманн-Ля Рош Аг |
Промотор
|
|
EP2176283B1
(en)
|
2007-07-14 |
2016-11-02 |
University of Iowa Research Foundation |
Methods and compositions for treating brain diseases
|
|
EP2019143A1
(en)
|
2007-07-23 |
2009-01-28 |
Genethon |
CNS gene delivery using peripheral administration of AAV vectors
|
|
PT2173888T
(pt)
|
2007-07-26 |
2016-11-17 |
Uniqure Ip Bv |
Resumo
|
|
CA2698011C
(en)
|
2007-09-04 |
2015-12-29 |
Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health |
Porcine adeno-associated viruses
|
|
JP2010538675A
(ja)
|
2007-09-19 |
2010-12-16 |
アムステルダム モレキュラー セラピューティクス ビー．ブイ． |
タンパク質産生の改善のためのａａｖ複製機構の使用
|
|
KR20090032547A
(ko)
|
2007-09-28 |
2009-04-01 |
씨제이제일제당 (주) |
채소류 추출물 발효액의 제조방법 및 이에 의해 제조된채소류 추출물 발효액
|
|
EP2058401A1
(en)
|
2007-10-05 |
2009-05-13 |
Genethon |
Widespread gene delivery to motor neurons using peripheral injection of AAV vectors
|
|
EP2186283A4
(en)
|
2007-10-18 |
2011-03-09 |
Lg Electronics Inc |
METHOD AND SYSTEM FOR TRANSMITTING AND RECEIVING SIGNALS
|
|
EP2212348B1
(en)
|
2007-11-02 |
2015-07-15 |
Cornell University |
Materials and methods for gene mediated therapy of psychiatric disorders
|
|
AU2008331905B2
(en)
|
2007-11-28 |
2014-09-18 |
The Trustees Of The University Of Pennsylvania |
Simian subfamily B adenovirus SAdV-28 and uses thereof
|
|
CA2706258C
(en)
|
2007-11-28 |
2017-06-06 |
The Trustees Of The University Of Pennsylvania |
Simian subfamily e adenoviruses sadv-39, -25.2, -26, -30, -37, and -38 and uses thereof
|
|
KR101614369B1
(ko)
|
2007-11-28 |
2016-04-21 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
유인원 아과 ｃ 아데노바이러스 ｓａｄｖ-40, -31, 및 -34 및 그것의 사용
|
|
AU2009209408B2
(en)
|
2008-01-29 |
2015-06-11 |
Beacon Therapeutics Limited |
Recombinant virus production using mammalian cells in suspension
|
|
CN102007209B
(zh)
|
2008-02-19 |
2013-11-13 |
阿姆斯特丹分子治疗(Amt)股份有限公司 |
细小病毒rep和cap蛋白在昆虫细胞中的表达优化
|
|
JP5661476B2
(ja)
|
2008-03-04 |
2015-01-28 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
サルアデノウイルスＳＡｄＶ−３６、−４２．１、−４２．２および−４４ならびにそれらの用途
|
|
WO2009134681A2
(en)
|
2008-04-30 |
2009-11-05 |
The Trustees Of The University Of Pennsylvania |
Aav7 viral vectors for targeted delivery of rpe cells
|
|
US8632764B2
(en)
|
2008-04-30 |
2014-01-21 |
University Of North Carolina At Chapel Hill |
Directed evolution and in vivo panning of virus vectors
|
|
EP2910637A1
(en)
|
2008-05-20 |
2015-08-26 |
University of Florida Research Foundation, Inc. |
Vectors for delivery of light-sensitive proteins and methods of use
|
|
US9217155B2
(en)
|
2008-05-28 |
2015-12-22 |
University Of Massachusetts |
Isolation of novel AAV'S and uses thereof
|
|
US20110171262A1
(en)
|
2008-06-17 |
2011-07-14 |
Andrew Christian Bakker |
Parvoviral capsid with incorporated gly-ala repeat region
|
|
US8945885B2
(en)
|
2008-07-03 |
2015-02-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Minicircle DNA vector preparations and methods of making and using the same
|
|
EA201170506A1
(ru)
|
2008-09-29 |
2011-12-30 |
Амстердам Молекьюлар Терапьютикс (Амт) Б.В. |
Генная терапия порфобилиногендезаминазой
|
|
US8940290B2
(en)
|
2008-10-31 |
2015-01-27 |
The Trustees Of The University Of Pennsylvania |
Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50 and uses thereof
|
|
WO2010093784A2
(en)
|
2009-02-11 |
2010-08-19 |
The University Of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
|
EP2403867B1
(en)
|
2009-03-04 |
2019-05-22 |
Deutsches Krebsforschungszentrum |
Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essential consisting of vp3
|
|
US20120093775A1
(en)
|
2009-03-27 |
2012-04-19 |
Proyecto De Biomedicina Cima, S.L. |
Methods and compositions for the treatment of cirrhosis and liver fibrosis
|
|
ES2724122T3
(es)
|
2009-04-30 |
2019-09-06 |
Univ Pennsylvania |
Composiciones para dirigir células de las vías respiratorias de conducción que comprenden construcciones de virus adenoasociado
|
|
EP3988660B1
(en)
|
2009-05-02 |
2025-05-14 |
Genzyme Corporation |
Gene therapy for neurodegenerative disorders
|
|
WO2010138263A2
(en)
|
2009-05-28 |
2010-12-02 |
University Of Massachusetts |
Novel aav 's and uses thereof
|
|
EP2435575A2
(en)
|
2009-05-28 |
2012-04-04 |
Deutsches Krebsforschungszentrum |
Modified aav capsid polypeptides
|
|
CN102575232B
(zh)
|
2009-05-29 |
2015-07-22 |
宾夕法尼亚大学托管会 |
猿腺病毒41及其应用
|
|
SMT201800554T1
(it)
|
2009-06-16 |
2018-11-09 |
Genzyme Corp |
Metodi migliorati per la purificazione di vettori di aav ricombinanti
|
|
EP2451823A4
(en)
|
2009-07-06 |
2013-07-03 |
Alnylam Pharmaceuticals Inc |
COMPOSITIONS AND METHODS FOR ENHANCING THE PRODUCTION OF A BIOLOGICAL PRODUCT
|
|
EP2292781A1
(en)
|
2009-08-17 |
2011-03-09 |
Genethon |
Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
|
|
WO2011038187A1
(en)
|
2009-09-25 |
2011-03-31 |
The Trustees Of The University Of Pennsylvania |
Controlled adeno-associated virus (aav) diversification and libraries prepared therefrom
|
|
US20120309816A1
(en)
|
2009-11-09 |
2012-12-06 |
Genepod Therapeutics Ab |
Novel viral vector construct for neuron specific optimized continuous DOPA synthesis in vivo
|
|
US8703749B2
(en)
|
2009-12-07 |
2014-04-22 |
Roberto Testi |
Compositions and methods for treating Friedreich's Ataxia
|
|
WO2011069529A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids
|
|
ES2683695T3
(es)
|
2010-01-12 |
2018-09-27 |
The University Of North Carolina At Chapel Hill |
Repeticiones terminales invertidas restrictivas para vectores virales
|
|
ES2628889T3
(es)
|
2010-02-05 |
2017-08-04 |
The University Of North Carolina At Chapel Hill |
Composiciones y métodos para la transducción mejorada del parvovirus
|
|
US9163261B2
(en)
|
2010-02-22 |
2015-10-20 |
Koteswara Rao KOLLIPARA |
Adeno-associated virus 2/8—micro RNA-101 therapy for liver cancer
|
|
US9228174B2
(en)
|
2010-03-11 |
2016-01-05 |
Uniqure Ip B.V. |
Mutated rep encoding sequences for use in AAV production
|
|
WO2011117258A2
(en)
|
2010-03-22 |
2011-09-29 |
Association Institut De Myologie |
Methods of increasing efficiency of vector penetration of target tissue
|
|
US9315825B2
(en)
|
2010-03-29 |
2016-04-19 |
The Trustees Of The University Of Pennsylvania |
Pharmacologically induced transgene ablation system
|
|
WO2011126808A2
(en)
|
2010-03-29 |
2011-10-13 |
The Trustees Of The University Of Pennsylvania |
Pharmacologically induced transgene ablation system
|
|
WO2011122950A1
(en)
|
2010-04-01 |
2011-10-06 |
Amsterdam Molecular Therapeutics (Amt) Ip B.V. |
Monomeric duplex aav vectors
|
|
CA2833905C
(en)
|
2010-04-23 |
2019-09-10 |
University Of Massachusetts |
Multicistronic expression constructs
|
|
EP3540055A1
(en)
|
2010-04-23 |
2019-09-18 |
University of Massachusetts |
Cns targeting aav vectors and methods of use thereof
|
|
US9272053B2
(en)
|
2010-04-23 |
2016-03-01 |
University Of Massachusetts |
AAV-based treatment of cholesterol-related disorders
|
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
US9839696B2
(en)
|
2010-04-30 |
2017-12-12 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
EP2394667A1
(en)
|
2010-06-10 |
2011-12-14 |
Laboratorios Del Dr. Esteve, S.A. |
Vectors and sequences for the treatment of diseases
|
|
PL2598525T3
(pl)
|
2010-07-28 |
2016-03-31 |
Roberto Testi |
Mutanty frataksyny
|
|
US8808684B2
(en)
|
2010-09-10 |
2014-08-19 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction
|
|
JP5010760B2
(ja)
|
2010-10-05 |
2012-08-29 |
タカラバイオ株式会社 |
ウイルスベクターの製造方法
|
|
US8663624B2
(en)
|
2010-10-06 |
2014-03-04 |
The Regents Of The University Of California |
Adeno-associated virus virions with variant capsid and methods of use thereof
|
|
JP6018069B2
(ja)
|
2010-10-12 |
2016-11-02 |
ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアＴｈｅ Ｃｈｉｌｄｒｅｎ’Ｓ Ｈｏｓｐｉｔａｌ Ｏｆ Ｐｈｉｌａｄｅｌｐｈｉａ |
血友病ｂを治療する方法及び組成物
|
|
EP2634253B1
(en)
|
2010-10-27 |
2016-05-11 |
Jichi Medical University |
Adeno-associated virus virions for transferring genes into neural cells
|
|
EP2637702A4
(en)
|
2010-11-11 |
2014-11-26 |
Univ Miami |
METHODS, COMPOSITIONS, CELLS AND KITS FOR TREATING ISCHEMIC INJURIES
|
|
EP2643465B1
(en)
|
2010-11-23 |
2016-05-11 |
The Trustees Of The University Of Pennsylvania |
Subfamily e simian adenovirus a1321 and uses thereof
|
|
US9044492B2
(en)
|
2011-02-04 |
2015-06-02 |
Cellectis Sa |
Method for modulating the efficiency of double-strand break-induced mutagenesis
|
|
SG10202007803QA
(en)
|
2011-02-17 |
2020-09-29 |
Univ Pennsylvania |
Compositions and methods for altering tissue specificity and improving aav9-mediated gene transfer
|
|
GB201103062D0
(en)
|
2011-02-22 |
2011-04-06 |
Isis Innovation |
Method
|
|
CN103492574B
(zh)
|
2011-02-22 |
2015-12-09 |
加州理工学院 |
使用腺相关病毒（aav）载体递送蛋白
|
|
EP2500434A1
(en)
|
2011-03-12 |
2012-09-19 |
Association Institut de Myologie |
Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
|
|
EP2700399B1
(en)
|
2011-04-18 |
2017-05-31 |
National Center of Neurology and Psychiatry |
Drug delivery particles and method for producing same
|
|
EP2699688A1
(en)
|
2011-04-20 |
2014-02-26 |
The Trustees Of The University Of Pennsylvania |
Regimens and compositions for aav-mediated passive immunization of airborne pathogens
|
|
LT3254703T
(lt)
|
2011-04-22 |
2020-05-25 |
The Regents Of The University Of California |
Adenoasocijuoto viruso virionai su variantine kapside ir jų panaudojimo būdai
|
|
US9249425B2
(en)
|
2011-05-16 |
2016-02-02 |
The Trustees Of The University Of Pennslyvania |
Proviral plasmids and production of recombinant adeno-associated virus
|
|
US9598468B2
(en)
|
2011-05-18 |
2017-03-21 |
University Of Florida Research Foundation, Incorporated |
Polypeptides and vectors for targeting HER2/neu expressing cells and uses thereof
|
|
CN103518132B
(zh)
|
2011-06-06 |
2015-11-25 |
拜奥卡蒂斯股份有限公司 |
通过离子型表面活性剂选择性裂解细胞
|
|
TWI678375B
(zh)
|
2011-06-09 |
2019-12-01 |
可娜公司 |
藉由抑制共濟蛋白（ｆｒａｔａｘｉｎ，ｆｘｎ）之天然反股轉錄本治療ｆｘｎ相關疾病
|
|
BR112014001863A2
(pt)
|
2011-07-27 |
2017-02-21 |
Genethon |
sistemas de expressão baculovírus melhorados
|
|
EP2748185A1
(en)
|
2011-08-24 |
2014-07-02 |
The Board of Trustees of The Leland Stanford Junior University |
New aav capsid proteins for nucleic acid transfer
|
|
EP2990477B8
(en)
|
2011-09-08 |
2018-10-31 |
uniQure IP B.V. |
Removal of contaminating viruses from aav preparations
|
|
WO2013036889A1
(en)
|
2011-09-09 |
2013-03-14 |
University Of Washington |
Retrograde transport peptide and use of same for delivery to central nervous system
|
|
GB201118636D0
(en)
|
2011-10-28 |
2011-12-07 |
Oxford Biomedica Ltd |
Nucleotide sequence
|
|
ES2609860T3
(es)
|
2011-10-28 |
2017-04-24 |
The University Of North Carolina At Chapel Hill |
Línea celular para la producción de virus adenoasociado
|
|
US20130136729A1
(en)
|
2011-11-11 |
2013-05-30 |
University of Virginia Patent Foundation, d/b/a University of Virginia Licensing & Ventures Group |
Compositions and methods for targeting and treating diseases and injuries using adeno-associated virus vectors
|
|
US10640785B2
(en)
|
2011-11-22 |
2020-05-05 |
The Children's Hospital Of Philadelphia |
Virus vectors for highly efficient transgene delivery
|
|
US9434928B2
(en)
|
2011-11-23 |
2016-09-06 |
Nationwide Children's Hospital, Inc. |
Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides
|
|
WO2013078199A2
(en)
|
2011-11-23 |
2013-05-30 |
Children's Medical Center Corporation |
Methods for enhanced in vivo delivery of synthetic, modified rnas
|
|
WO2013096955A1
(en)
|
2011-12-23 |
2013-06-27 |
Case Western Reserve University |
Targeted gene modification using hybrid recombinant adeno-associated virus
|
|
WO2013103896A1
(en)
|
2012-01-06 |
2013-07-11 |
Mayo Foundation For Medical Education And Research |
Treating cardiovascular or renal diseases
|
|
EP2812452B1
(en)
*
|
2012-02-09 |
2020-05-27 |
Population Bio, Inc. |
Methods and compositions for screening and treating developmental disorders
|
|
KR102107482B1
(ko)
|
2012-02-14 |
2020-05-08 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
심혈관 질환 및 다른 증상에 대한 파라크린 유전자의 전신 전달 및 조절 발현
|
|
CN104520428B
(zh)
|
2012-02-17 |
2018-09-21 |
费城儿童医院 |
将基因转移到细胞、器官和组织的aav载体组合物和方法
|
|
CA2870736C
(en)
|
2012-04-18 |
2021-11-02 |
The Children's Hospital Of Philadelphia |
Composition and methods for highly efficient gene transfer using aav capsid variants
|
|
US20140162319A2
(en)
|
2012-05-02 |
2014-06-12 |
Sangeetha Hareendran |
Nucleotide sequences, methods, kit and a recombinant cell thereof
|
|
US9163259B2
(en)
|
2012-05-04 |
2015-10-20 |
Novartis Ag |
Viral vectors for the treatment of retinal dystrophy
|
|
JP6385920B2
(ja)
|
2012-05-09 |
2018-09-05 |
オレゴン ヘルス アンド サイエンス ユニバーシティー |
アデノ随伴ウイルスプラスミド及びベクター
|
|
US10294281B2
(en)
|
2012-05-15 |
2019-05-21 |
University Of Florida Research Foundation, Incorporated |
High-transduction-efficiency rAAV vectors, compositions, and methods of use
|
|
TWI775096B
(zh)
|
2012-05-15 |
2022-08-21 |
澳大利亞商艾佛蘭屈澳洲私營有限公司 |
使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd)
|
|
KR20150014505A
(ko)
|
2012-05-18 |
2015-02-06 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
아과 e 원숭이 아데노바이러스 a1302, a1320, a1331 및 a1337 및 이것들의 사용
|
|
RU2679843C2
(ru)
|
2012-07-06 |
2019-02-13 |
Юниверсити Оф Айова Рисерч Фаундейшн |
Векторные композиции с модифицированным аденоассоциированным вирусом
|
|
WO2014007120A1
(ja)
|
2012-07-06 |
2014-01-09 |
タカラバイオ株式会社 |
アデノ随伴ウイルスベクターの産生細胞
|
|
PT2879719T
(pt)
|
2012-08-01 |
2018-10-08 |
Ohio State Innovation Foundation |
Administração intratecal do vírus adeno-associado 9 recombinante
|
|
US10166299B2
(en)
|
2012-08-31 |
2019-01-01 |
The United States Of America As Represented By The Secretary Dept. Of Health And Human Services National Institutes Of Health |
AAV mediated aquaporin gene transfer to treat Sjogren's syndrome
|
|
EP3738974A1
(en)
|
2012-09-28 |
2020-11-18 |
The University of North Carolina at Chapel Hill |
Aav vectors targeted to oligodendrocytes
|
|
JP6363958B2
(ja)
|
2012-12-25 |
2018-07-25 |
タカラバイオ株式会社 |
Ａａｖ変異体
|
|
BR122020002822B1
(pt)
|
2013-01-08 |
2023-04-18 |
Genzyme Corporation |
Método para cultivar um vetor de hsv-1 d27.1
|
|
US20150352228A1
(en)
|
2013-01-11 |
2015-12-10 |
Bruce TORBET |
Methods and compositions for enhancing transduction efficiency of retroviral vectors
|
|
US9066966B2
(en)
|
2013-02-01 |
2015-06-30 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxia
|
|
DK2954051T3
(da)
|
2013-02-08 |
2019-07-08 |
Univ Pennsylvania |
Modificeret kapsid til genoverførsel til behandling af nethinden
|
|
CA2905952A1
(en)
|
2013-03-13 |
2014-10-02 |
The Children's Hospital Of Philadelphia |
Adeno-associated virus vectors and methods of use thereof
|
|
HK1220488A1
(zh)
|
2013-03-15 |
2017-05-05 |
The Children's Hospital Of Philadelphia |
含有填充者/填充物多核苷酸序列的载体及其使用方法
|
|
US9447433B2
(en)
|
2013-03-15 |
2016-09-20 |
The University Of North Carolina At Chapel Hill |
Synthetic adeno-associated virus inverted terminal repeats
|
|
IL293294B2
(en)
|
2013-03-15 |
2023-04-01 |
Univ North Carolina Chapel Hill |
Methods and compounds for ligation of paired aav glycan vectors
|
|
AU2014251099B2
(en)
|
2013-04-08 |
2019-01-17 |
The University Of Kansas |
Chimeric adeno-associated virus/ bocavirus parvovirus vector
|
|
EP2792742A1
(en)
|
2013-04-17 |
2014-10-22 |
Universitätsklinikum Hamburg-Eppendorf (UKE) |
Gene-therapy vectors for treating cardiomyopathy
|
|
EP2986635B1
(en)
|
2013-04-18 |
2018-10-03 |
Fondazione Telethon |
Effective delivery of large genes by dual aav vectors
|
|
CN109652385A
(zh)
|
2013-04-20 |
2019-04-19 |
全国儿童医院研究所 |
外显子2靶向U7snRNA多核苷酸构建体的重组腺相关病毒递送
|
|
US9719106B2
(en)
|
2013-04-29 |
2017-08-01 |
The Trustees Of The University Of Pennsylvania |
Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
|
|
AU2013388083B2
(en)
|
2013-05-01 |
2019-08-22 |
Genzyme Corporation |
Compositions and methods for treating spinal muscular atrophy
|
|
CA2912678C
(en)
|
2013-05-15 |
2023-10-10 |
Regents Of The University Of Minnesota |
Adeno-associated virus mediated gene transfer to the central nervous system
|
|
US10006049B2
(en)
|
2013-05-16 |
2018-06-26 |
University Of Florida Research Foundation, Incorporated |
Hairpin mRNA elements and methods for the regulation of protein translation
|
|
WO2014194132A1
(en)
|
2013-05-31 |
2014-12-04 |
The Regents Of The University Of California |
Adeno-associated virus variants and methods of use thereof
|
|
WO2014201308A1
(en)
|
2013-06-12 |
2014-12-18 |
Washington University |
Endothelial-targeted adenoviral vectors, methods and uses therefor
|
|
US20160122727A1
(en)
|
2013-06-13 |
2016-05-05 |
Shire Human Genetic Therapies, Inc. |
Messenger rna based viral production
|
|
PH12016500162B1
(en)
|
2013-07-22 |
2024-02-21 |
Childrens Hospital Philadelphia |
Variant aav and compositions, methods and uses for gene trnsfer to cells, organs, and tissues
|
|
RU2018128780A
(ru)
|
2013-07-26 |
2018-12-05 |
Юниверсити Оф Айова Рисерч Фаундейшн |
Способы и композиции для лечения болезней мозга
|
|
ITTO20130669A1
(it)
|
2013-08-05 |
2015-02-06 |
Consiglio Nazionale Ricerche |
Vettore adeno-associato ricombinante muscolo-specifico e suo impiego nel trattamento di patologie muscolari
|
|
US11078464B2
(en)
|
2013-08-30 |
2021-08-03 |
Amgen Inc. |
High titer recombinant AAV vector production in adherent and suspension cells
|
|
CA3178379A1
(en)
|
2013-09-12 |
2015-03-19 |
Biomarin Pharmaceutical Inc. |
Adeno-associated virus factor viii vectors
|
|
EP3564379A1
(en)
|
2013-09-13 |
2019-11-06 |
California Institute of Technology |
Selective recovery
|
|
SI3046536T1
(sl)
|
2013-09-19 |
2019-05-31 |
Janssen Vaccines & Prevention B.V. |
Izboljšane formulacije adenovirusa
|
|
US20160354489A1
(en)
|
2013-09-26 |
2016-12-08 |
Universitat Autònome de Barcelona |
Gene therapy compositions for use in the prevention and/or treatment of non-alcoholic fatty liver disease
|
|
EP3633041A3
(en)
|
2013-09-26 |
2020-07-29 |
University of Florida Research Foundation, Inc. |
Synthetic combinatorial aav capsid library for targeted gene therapy
|
|
NZ758025A
(en)
|
2013-10-11 |
2022-07-01 |
Massachusetts Eye & Ear Infirmary |
Methods of predicting ancestral virus sequences and uses thereof
|
|
WO2015060722A1
(en)
|
2013-10-24 |
2015-04-30 |
Uniqure Ip B.V. |
Aav-5 pseudotyped vector for gene therapy for neurological diseases
|
|
US10087224B2
(en)
|
2013-11-01 |
2018-10-02 |
Cornell University |
Gene therapy for Alzheimer's and other neurodegenerative diseases and conditions
|
|
US20160272687A1
(en)
|
2013-11-08 |
2016-09-22 |
The Board Of Trustees Of The University Of Arkansas |
Adeno-associated virus "x" oncogene
|
|
WO2015081101A1
(en)
|
2013-11-26 |
2015-06-04 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Services |
Adeno-associated virus vectors for treatment of glycogen storage disease
|
|
KR102245861B1
(ko)
|
2013-11-29 |
2021-04-28 |
다카라 바이오 가부시키가이샤 |
아데노 수반 바이러스의 정량 방법
|
|
EP3080269B1
(en)
|
2013-12-09 |
2019-05-22 |
Baylor College of Medicine |
Hippo and dystrophin complex signaling in cardiomyocyte renewal
|
|
WO2015089351A1
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Compositions and methods of use of crispr-cas systems in nucleotide repeat disorders
|
|
GB201322798D0
(en)
|
2013-12-20 |
2014-02-05 |
Oxford Biomedica Ltd |
Production system
|
|
ES2732208T3
(es)
|
2014-01-09 |
2019-11-21 |
Genethon |
Métodos para el diagnóstico o el seguimiento de distrofias musculares
|
|
GB201401707D0
(en)
|
2014-01-31 |
2014-03-19 |
Sec Dep For Health The |
Adeno-associated viral vectors
|
|
GB201403684D0
(en)
|
2014-03-03 |
2014-04-16 |
King S College London |
Vector
|
|
WO2015124546A1
(en)
|
2014-02-19 |
2015-08-27 |
Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii- Cnic |
Aav vectors for the treatment of ischemic and non-ischemic heart disease
|
|
RU2016136989A
(ru)
|
2014-02-19 |
2018-03-22 |
Ф.Хоффманн-Ля Рош Аг |
Шаттл для гематоэнцефалического барьера
|
|
WO2015127128A2
(en)
|
2014-02-19 |
2015-08-27 |
University Of Massachusetts |
Recombinant aavs having useful transcytosis properties
|
|
US20170007720A1
(en)
|
2014-02-21 |
2017-01-12 |
University Of Florida Research Foundation, Inc. |
Methods and compositions for gene delivery to on bipolar cells
|
|
WO2015131076A1
(en)
|
2014-02-27 |
2015-09-03 |
Yale University |
Nlrp6 inflammasome intestinal epithelium mucus secretion
|
|
EP3113787B1
(en)
|
2014-03-04 |
2019-12-04 |
University of Florida Research Foundation, Inc. |
Improved raav vectors and methods for transduction of photoreceptors and rpe cells
|
|
SI3116900T1
(sl)
|
2014-03-09 |
2021-02-26 |
The Trustees Of The University Of Pennsylvania |
Sestavki uporabni pri zdravljenju pomanjkanja ornitin transkarbamilaze(OTC)
|
|
ES2990174T3
(es)
|
2014-03-10 |
2024-11-29 |
Uniqure Ip Bv |
Vectores de AAV mejorados producidos en células de insecto
|
|
DE102014207498A1
(de)
|
2014-04-17 |
2015-10-22 |
Universitätsklinikum Hamburg-Eppendorf |
Viraler Vektor für den zielgerichteten Gentransfer in Gehirn und Rückenmark
|
|
EP2933335A1
(en)
|
2014-04-18 |
2015-10-21 |
Genethon |
A method of treating peripheral neuropathies and motor neuron diseases
|
|
EP3134522B1
(en)
|
2014-04-25 |
2021-10-06 |
University of Massachusetts |
Recombinant aav vectors useful for reducing immunity against transgene products
|
|
WO2015164778A1
(en)
|
2014-04-25 |
2015-10-29 |
The Trustees Of The University Of Pennysylvania |
Ldlr variants and their use in compositions for reducing cholesterol levels
|
|
LT3137497T
(lt)
|
2014-05-02 |
2021-07-26 |
Genzyme Corporation |
Aav vektoriai, skirti tinklainės ir cns genų terapijai
|
|
EP3151866B1
(en)
|
2014-06-09 |
2023-03-08 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
WO2015192063A1
(en)
|
2014-06-13 |
2015-12-17 |
Yasuhiro Ikeda |
Methods and materials for increasing viral vector infectivity
|
|
CN106459999B
(zh)
|
2014-06-18 |
2024-10-11 |
新加坡科技研究局 |
用于高水平表达的新型启动子
|
|
US10781459B2
(en)
|
2014-06-20 |
2020-09-22 |
University Of Florida Research Foundation, Incorporated |
Methods of packaging multiple adeno-associated virus vectors
|
|
EP2960336A1
(en)
|
2014-06-27 |
2015-12-30 |
Genethon |
Efficient systemic treatment of dystrophic muscle pathologies
|
|
WO2016004319A1
(en)
|
2014-07-02 |
2016-01-07 |
University Of Florida Research Foundation, Inc. |
Compositions and methods for purifying recombinant adeno-associated virus
|
|
CN106662401A
(zh)
|
2014-07-07 |
2017-05-10 |
株式会社Ihi |
热处理装置
|
|
US10023846B2
(en)
|
2014-07-10 |
2018-07-17 |
Takara Bio Inc. |
Production method for non-enveloped virus particles
|
|
WO2016019364A1
(en)
|
2014-08-01 |
2016-02-04 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for self-regulated inducible gene expression
|
|
EP3800260A1
(en)
|
2014-09-24 |
2021-04-07 |
City of Hope |
Adeno-associated virus vector variants for high efficiency genome editing and methods thereof
|
|
JP6842410B2
(ja)
|
2014-10-03 |
2021-03-17 |
ユニバーシティ オブ マサチューセッツ |
新規の高効率ライブラリーにより同定されるａａｖベクター
|
|
WO2016054554A1
(en)
|
2014-10-03 |
2016-04-07 |
University Of Massachusetts |
Heterologous targeting peptide grafted aavs
|
|
WO2016057975A2
(en)
|
2014-10-10 |
2016-04-14 |
Research Institute At Nationwide Children's Hospital |
Guided injections for aav gene transfer to muscle
|
|
RU2738421C2
(ru)
|
2014-10-21 |
2020-12-14 |
Юниверсити Оф Массачусетс |
Варианты рекомбинантных aav и их применения
|
|
KR20170096998A
(ko)
|
2014-11-05 |
2017-08-25 |
보이저 테라퓨틱스, 인크. |
파킨슨병의 치료를 위한 aadc 폴리뉴클레오티드
|
|
AU2015342997B2
(en)
|
2014-11-05 |
2021-11-18 |
Research Institute At Nationwide Children's Hospital |
Methods and materials for producing recombinant viruses in eukaryotic microalgae
|
|
WO2016077689A1
(en)
|
2014-11-14 |
2016-05-19 |
Voyager Therapeutics, Inc. |
Modulatory polynucleotides
|
|
AU2015349759B2
(en)
|
2014-11-21 |
2022-01-06 |
The University Of North Carolina At Chapel Hill |
Aav vectors targeted to the central nervous system
|
|
WO2016081927A2
(en)
|
2014-11-21 |
2016-05-26 |
University Of Florida Research Foundation, Inc. |
Genome-modified recombinant adeno-associated virus vectors
|
|
DK3224376T4
(da)
|
2014-11-28 |
2023-05-30 |
Uniqure Ip Bv |
DNA-forureninger i en sammensætning omfattende en parvoviral virion
|
|
WO2016094783A1
(en)
|
2014-12-12 |
2016-06-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for the production of scaav
|
|
US10907176B2
(en)
|
2015-01-14 |
2021-02-02 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for targeted gene transfer
|
|
MX2017009336A
(es)
*
|
2015-01-16 |
2017-11-15 |
Voyager Therapeutics Inc |
Polinucleótidos dirigidos al sistema nervioso central.
|
|
US20180008727A1
(en)
|
2015-01-30 |
2018-01-11 |
The Regents Of The University Of California |
Spinal subpial gene delivery system
|
|
US20180030096A1
(en)
|
2015-02-03 |
2018-02-01 |
University Of Florida Research Foundation, Inc. |
Recombinant aav1, aav5, and aav6 capsid mutants and uses thereof
|
|
CR20170407A
(es)
|
2015-02-10 |
2017-11-14 |
Genzyme Corp |
Mejora del suministro de partículas virales al cuerpo estriado y al córtex
|
|
ES2920850T3
(es)
|
2015-02-20 |
2022-08-10 |
Univ Iowa Res Found |
Procedimientos y composiciones para el tratamiento de enfermedades oculares genéticas
|
|
US20180245073A1
(en)
|
2015-02-23 |
2018-08-30 |
Voyager Therapeutics, Inc. |
Regulatable expression using adeno-associated virus (aav)
|
|
WO2016145217A1
(en)
*
|
2015-03-10 |
2016-09-15 |
The Trustees Of Columbia University In The City Of New York |
Recombinant glut1 adeno-associated viral vector constructs and related methods for restoring glut1 expression
|
|
AU2016235421A1
(en)
|
2015-03-20 |
2017-10-12 |
Bluebird Bio, Inc. |
Vector formulations
|
|
US11040113B2
(en)
|
2015-03-23 |
2021-06-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical composition for the treatment and the prevention of neurological phenotype associated with Friedreich ataxia
|
|
WO2016154344A1
(en)
|
2015-03-24 |
2016-09-29 |
The Regents Of The University Of California |
Adeno-associated virus variants and methods of use thereof
|
|
US10081659B2
(en)
|
2015-04-06 |
2018-09-25 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Adeno-associated vectors for enhanced transduction and reduced immunogenicity
|
|
TWI707951B
(zh)
|
2015-04-08 |
2020-10-21 |
美商健臻公司 |
過大腺相關載體之製造
|
|
CN115094062A
(zh)
|
2015-04-16 |
2022-09-23 |
埃默里大学 |
用于肝脏中蛋白质表达的重组启动子和载体及其用途
|
|
US11020443B2
(en)
|
2015-04-23 |
2021-06-01 |
University Of Massachusetts |
Modulation of AAV vector transgene expression
|
|
WO2016172659A1
(en)
|
2015-04-24 |
2016-10-27 |
University Of Florida Research Foundation, Inc. |
Aav vector for treatment of friedreich's ataxia
|
|
US11046955B2
(en)
|
2015-04-24 |
2021-06-29 |
University Of Massachusetts |
Modified AAV constructs and uses thereof
|
|
AU2016256894B2
(en)
|
2015-05-07 |
2020-11-26 |
Massachusetts Eye And Ear Infirmary |
Methods of delivering an agent to the eye
|
|
EP3294398A4
(en)
|
2015-05-11 |
2019-01-09 |
Alcyone Lifesciences, Inc. |
SYSTEM AND METHOD FOR THE ADMINISTRATION OF MEDICAMENTS
|
|
CA2985786A1
(en)
|
2015-05-12 |
2016-11-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Aav isolate and fusion protein comprising nerve growth factor signal peptide and parathyroid hormone
|
|
US20170067028A1
(en)
|
2015-05-15 |
2017-03-09 |
Douglas J. Ballon |
Radiolabeling of adeno associated virus
|
|
US10729790B2
(en)
|
2015-05-26 |
2020-08-04 |
Salk Institute For Biological Studies |
Motor neuron-specific expression vectors
|
|
CA2987103A1
(en)
|
2015-05-28 |
2016-12-01 |
Cornell University |
Adeno-associated virus mediated delivery of c1ei as a therapy for angioedema
|
|
WO2016196507A1
(en)
|
2015-05-29 |
2016-12-08 |
University Of Iowa Research Foundation |
Methods of delivery of transgenes for treating brain diseases
|
|
CA2990193A1
(en)
|
2015-06-23 |
2016-12-29 |
The Children's Hospital Of Philadelphia |
Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues
|
|
US11266748B2
(en)
|
2015-07-02 |
2022-03-08 |
University Of Florida Research Foundation, Incorporated |
Recombinant adeno-associated virus vectors to target medullary thyroid carcinoma
|
|
US20170007669A1
(en)
|
2015-07-07 |
2017-01-12 |
Mayo Foundation For Medical Education And Research |
Peptide-mediated delivery of active agents across the blood-brain barrier
|
|
ES2895652T3
(es)
|
2015-07-07 |
2022-02-22 |
Inst Nat Sante Rech Med |
Métodos y composiciones farmacéuticas para expresar un polinucleótido de interés en el sistema nervioso periférico de un sujeto
|
|
US20180216133A1
(en)
|
2015-07-17 |
2018-08-02 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for achieving high levels of transduction in human liver cells
|
|
US20180214576A1
(en)
|
2015-07-28 |
2018-08-02 |
University Of Massachusetts |
Transgenic expression of dnasei in vivo delivered by an adeno-associated virus vector
|
|
CA2994160C
(en)
|
2015-07-30 |
2021-08-10 |
Massachusetts Eye And Ear Infirmary |
Ancestral virus sequences and uses thereof
|
|
WO2017023724A1
(en)
|
2015-07-31 |
2017-02-09 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of aadc deficiency
|
|
HK1256909A1
(zh)
|
2015-08-06 |
2019-10-04 |
宾夕法尼亚大学 |
Glp-1和其在用於治疗代谢疾病的组合物中的用途
|
|
MX2018003702A
(es)
|
2015-09-24 |
2018-04-30 |
Biomarin Pharm Inc |
Vectores del factor viii del virus adenoasociado, particulas viricas asociadas y formulaciones terapeuticas que las comprenden.
|
|
PT3356390T
(pt)
|
2015-09-28 |
2021-04-21 |
Univ Florida |
Métodos e composições para vetores virais que se evadem a anticorpos
|
|
EP4530350A3
(en)
|
2015-10-09 |
2025-06-25 |
Genzyme Corporation |
Improved flare (flow cytometry attenuated reporter expression) technology for rapid bulk sorting
|
|
US10123969B2
(en)
|
2015-10-15 |
2018-11-13 |
Wisconsin Alumni Research Foundation |
Osmotic enhancement of drug/therapeutic delivery to the brain following infusion or injection into the cerebrospinal fluid
|
|
WO2017066764A2
(en)
|
2015-10-16 |
2017-04-20 |
William Marsh Rice University |
Modification of n-terminal region of capsid proteins for enhanced properties of adeno-associated viruses
|
|
DK3364997T5
(da)
|
2015-10-22 |
2024-09-30 |
Univ Massachusetts |
Aspartoacylase genterapi til behandling af canavans sygdom
|
|
WO2017070516A1
(en)
|
2015-10-22 |
2017-04-27 |
University Of Massachusetts |
Prostate-targeting adeno-associated virus serotype vectors
|
|
US12188037B2
(en)
|
2015-10-22 |
2025-01-07 |
University Of Florida Research Foundation, Incorporated |
Synthetic combinatorial AAV3 capsid library
|
|
SG11201803218PA
(en)
|
2015-10-23 |
2018-05-30 |
Univ Iowa Res Found |
Methods for treating neurodegenerative diseases using gene therapy to delay disease onset and progression while providing cognitive protection
|
|
EP3368054A4
(en)
|
2015-10-28 |
2019-07-03 |
Voyager Therapeutics, Inc. |
REGULATORY EXPRESSION USING THE ADENO-ASSOCIATED VIRUS (AAV)
|
|
HK1258413A1
(zh)
|
2015-10-29 |
2019-11-08 |
Voyager Therapeutics, Inc. |
遞送中樞神經系統(cns)靶向多核苷酸
|
|
WO2017077451A1
(en)
*
|
2015-11-05 |
2017-05-11 |
Bamboo Therapeutics, Inc. |
Modified friedreich ataxia genes and vectors for gene therapy
|
|
US10633662B2
(en)
|
2015-11-10 |
2020-04-28 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for modulating AAV infection
|
|
WO2017083722A1
(en)
|
2015-11-11 |
2017-05-18 |
Greenberg Kenneth P |
Crispr compositions and methods of using the same for gene therapy
|
|
US10240145B2
(en)
|
2015-11-25 |
2019-03-26 |
The Board Of Trustees Of The Leland Stanford Junior University |
CRISPR/Cas-mediated genome editing to treat EGFR-mutant lung cancer
|
|
US20170151416A1
(en)
|
2015-12-01 |
2017-06-01 |
Invivo Therapeutics Corporation |
Methods and Systems for Delivery of a Trail of a Therapeutic Substance into an Anatomical Space
|
|
MX2018006682A
(es)
|
2015-12-01 |
2018-09-26 |
Spark Therapeutics Inc |
Metodos escalables para producir vector viral adenoasociado (aav) recombinante en un sistema de cultivo celular en suspension libre de suero adecuado para su uso clinico.
|
|
US10406244B2
(en)
|
2015-12-02 |
2019-09-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
AAV vectors with expanded packaging capacity
|
|
WO2017096164A1
(en)
|
2015-12-02 |
2017-06-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Novel recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism
|
|
WO2017093330A1
(en)
|
2015-12-03 |
2017-06-08 |
Genethon |
Compositions and methods for improving viral vector efficiency
|
|
EP3387138B1
(en)
|
2015-12-11 |
2022-01-26 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav9
|
|
WO2017100674A1
(en)
|
2015-12-11 |
2017-06-15 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav1
|
|
WO2017100671A1
(en)
|
2015-12-11 |
2017-06-15 |
California Institute Of Technology |
TARGETING PEPTIDES FOR DIRECTING ADENO-ASSOCIATED VIRUSES (AAVs)
|
|
EP3387117B1
(en)
|
2015-12-11 |
2022-11-23 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav8
|
|
ES2918998T3
(es)
|
2015-12-11 |
2022-07-21 |
Univ Pennsylvania |
Método de purificación escalable para AAVrh10
|
|
CN116478254A
(zh)
|
2015-12-14 |
2023-07-25 |
北卡罗来纳大学教堂山分校 |
增强细小病毒载体递送的修饰衣壳蛋白
|
|
US11208630B2
(en)
|
2015-12-24 |
2021-12-28 |
University Of Florida Research Foundation, Incorporated |
AAV production using suspension adapted cells
|
|
HUE051774T2
(hu)
|
2016-01-13 |
2021-03-29 |
Genzyme Corp |
Oszteoprotektív géneket, például HAS2-t és lubricint expresszáló rekombináns AAV vektorok, amelyek alkalmazhatók emlõsben oszteoartritisz és azzal kapcsolatos ízületi állapotok kezelésében
|
|
EP3403675B1
(en)
|
2016-01-15 |
2021-04-21 |
Jichi Medical University |
Adeno-associated virus virion for use in treatment of epilepsy
|
|
EP3411059A4
(en)
|
2016-02-02 |
2019-10-16 |
University Of Massachusetts |
METHOD FOR INCREASING THE EFFECTIVENESS OF THE SYSTEMIC DELIVERY OF AVV GENES TO THE CENTRAL NERVOUS SYSTEM
|
|
HRP20231451T1
(hr)
|
2016-02-05 |
2024-03-01 |
Emory University |
Ubrizgavanje jednolančanog ili samo-komplementarnog adeno-povezanog virusa 9 u cerebrospinalnu tekućinu
|
|
US11702672B2
(en)
|
2016-02-08 |
2023-07-18 |
University Of Iowa Research Foundation |
Methods to produce chimeric adeno-associated virus/bocavirus parvovirus
|
|
US10179176B2
(en)
|
2016-02-16 |
2019-01-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies
|
|
US20190071681A1
(en)
|
2016-02-26 |
2019-03-07 |
University Of Florida Research Foundation, Incorporated |
Aav heparin mutants that display significantly improved eye and brain transduction
|
|
JP7436089B2
(ja)
|
2016-03-02 |
2024-02-21 |
ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア |
前頭側頭型認知症の治療
|
|
CN115287301A
(zh)
|
2016-03-03 |
2022-11-04 |
马萨诸塞大学 |
用于非病毒基因转移的末端封闭型线性双链体dna
|
|
EP3426787A1
(en)
|
2016-03-07 |
2019-01-16 |
University of Iowa Research Foundation |
Aav-mediated expression using a synthetic promoter and enhancer
|
|
US11155817B2
(en)
|
2016-03-18 |
2021-10-26 |
The Children's Hospital Of Philadelphia |
Therapeutic for treatment of diseases including the central nervous system
|
|
AU2017237912B2
(en)
|
2016-03-23 |
2022-03-10 |
The Regents Of The University Of California |
Methods of treating mitochondrial disorders
|
|
WO2017165859A1
(en)
|
2016-03-24 |
2017-09-28 |
Research Institute At Nationwide Children's Hospital |
Modified viral capsid proteins
|
|
DK3436593T3
(da)
|
2016-03-28 |
2023-02-20 |
Ultragenyx Pharmaceutical Inc |
Fremgangsmåder til varmeinaktivering af adenovirus
|
|
CN109563153B
(zh)
|
2016-03-28 |
2022-09-02 |
加利福尼亚大学董事会 |
抗-ryk抗体及使用其的方法
|
|
CA3019126A1
(en)
|
2016-03-30 |
2017-10-05 |
Spark Therapeutics, Inc. |
Cell line for recombinant protein and/or viral vector production
|
|
BR112018070256A2
(pt)
|
2016-03-31 |
2019-01-29 |
Spark Therapeutics Inc |
processo de fabricação de raav totalmente escalável à base de colunas
|
|
US11091776B2
(en)
|
2016-04-15 |
2021-08-17 |
The Trustees Of The University Of Pennsylvania |
AAV8 mutant capsids and compositions containing same
|
|
AU2017248840B2
(en)
|
2016-04-16 |
2022-07-28 |
University Of Florida Research Foundation, Incorporated |
Methods of enhancing biological potency of baculovirus system-produced recombinant adeno-associated virus
|
|
JP7496667B2
(ja)
|
2016-04-21 |
2024-06-07 |
ビロベク，インコーポレイテッド |
昆虫細胞中でのａａｖ生成、方法およびその組成物
|
|
EP3235516B1
(en)
|
2016-04-22 |
2019-06-26 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Universitätsmedizin |
Regulatable adeno-associated virus (aav) vector
|
|
EP3449250B1
(en)
|
2016-04-28 |
2020-11-04 |
Indiana University Research & Technology Corporation |
Methods and compositions for resolving components of a virus preparation
|
|
EP3452495B1
(en)
|
2016-05-03 |
2021-06-23 |
Children's Medical Research Institute |
Adeno-associated virus polynucleotides, polypeptides and virions
|
|
WO2017192750A1
(en)
|
2016-05-04 |
2017-11-09 |
Oregon Health & Science University |
Recombinant adeno-associated viral vectors
|
|
WO2018089527A1
(en)
|
2016-11-09 |
2018-05-17 |
Intrexon Corporation |
Frataxin expression constructs
|
|
IL268534B2
(en)
|
2017-02-15 |
2024-10-01 |
Univ North Carolina Chapel Hill |
Methods and compositions for gene transfer across the vasculature
|
|
WO2018156654A1
(en)
|
2017-02-21 |
2018-08-30 |
University Of Florida Research Foundation, Incorporated |
Modified aav capsid proteins and uses thereof
|
|
SI3645551T1
(sl)
|
2017-06-27 |
2024-06-28 |
Regeneron Pharmaceuticals, Inc. |
S tropizmi spremenjeni rekombinantni virusni vektorji in njihova uporaba za tarčni vnos genetskega materiala v človeške celice
|
|
CN110461368A
(zh)
|
2017-06-30 |
2019-11-15 |
加利福尼亚大学董事会 |
具有变异衣壳的腺相关病毒病毒体及其使用方法
|
|
US20190008919A1
(en)
|
2017-07-08 |
2019-01-10 |
Ghassan S. Kassab |
Eta receptor antagonists and methods of using the same to treat cardiovascular disorders and disease
|
|
EP3662060A2
(en)
*
|
2017-08-03 |
2020-06-10 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
EP3676373A4
(en)
|
2017-08-28 |
2021-06-09 |
The Regents of The University of California |
Adeno-associated virus capsid variants and methods of use thereof
|
|
DK3684423T5
(da)
|
2017-09-20 |
2024-08-26 |
4D Molecular Therapeutics Inc |
Adeno-associerede virusvariantcapsider og fremgangsmåder til anvendelse deraf
|
|
CA3075656A1
(en)
|
2017-09-29 |
2019-04-04 |
Voyager Therapeutics, Inc. |
Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous delivery
|
|
WO2019079240A1
(en)
|
2017-10-16 |
2019-04-25 |
Voyager Therapeutics, Inc. |
TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
|
|
WO2019076973A1
(en)
|
2017-10-17 |
2019-04-25 |
Fundació Institut D'investigació En Ciències De La Salut Germans Trias I Pujol |
VECTORS FOR THE TREATMENT OF FRIEDREICH ATAXIA
|
|
CN111902539B
(zh)
|
2018-02-07 |
2025-05-16 |
吉尼松公司 |
杂合调控元件
|
|
TW202015742A
(zh)
|
2018-05-15 |
2020-05-01 |
美商航海家醫療公司 |
投遞腺相關病毒（ａａｖ）之組成物和方法
|
|
US20210214749A1
(en)
|
2018-05-16 |
2021-07-15 |
Voyager Therapeutics, Inc. |
Directed evolution
|
|
EP3856913A4
(en)
|
2018-09-26 |
2022-10-26 |
California Institute Of Technology |
Adeno-associated virus compositions for targeted gene therapy
|
|
JP7528066B2
(ja)
|
2018-09-28 |
2024-08-05 |
ボイジャー セラピューティクス インコーポレイテッド |
操作されたプロモータを有するフラタキシン発現コンストラクトおよびその使用方法
|